An excerpt from the NY Times -
New Drug Offers Hope to Millions With Severe Migraines
By Gina Kolata
The first medicine designed to prevent migraines was approved by the Food and Drug Administration on Thursday, ushering in what many experts believe will be a new era in treatment for people who suffer the most severe form of these headaches.
The drug, Aimovig, made by Amgen and Novartis, is a monthly injection with a device similar to an insulin pen. The list price will be $6,900 a year, and Amgen said the drug will be available to patients within a week.
https://www.nytimes.com/2018/05/17/health/migraines-prevention-drug-aimovig.html?emc=edit_na_20180517&nl=breaking-news&nlid=38867499ing-news&ref=cta
No comments:
Post a Comment